AGA clinical practice update on the evaluation and management of acute kidney injury in patients with cirrhosis: expert review
Description The purpose of this American Gastroenterological Association (AGA) Institute
Clinical Practice Update is to review the available published evidence and expert advice …
Clinical Practice Update is to review the available published evidence and expert advice …
Management of hepatorenal syndrome in liver cirrhosis: a recent update
Hepatorenal syndrome (HRS) is a serious form of renal dysfunction in patients with cirrhosis
and ascites. It is an important component of the acute-on-chronic liver failure (ACLF) …
and ascites. It is an important component of the acute-on-chronic liver failure (ACLF) …
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies
MP Curry, HE Vargas, AS Befeler… - Hepatology …, 2023 - journals.lww.com
Abstract Hepatorenal syndrome type 1 (HRS-1) is a serious complication of advanced
cirrhosis and a potentially reversible form of acute kidney injury that is associated with …
cirrhosis and a potentially reversible form of acute kidney injury that is associated with …
[HTML][HTML] Acute-on-chronic liver failure: Terminology, mechanisms and management
VK Br, SK Sarin - Clinical and Molecular Hepatology, 2023 - ncbi.nlm.nih.gov
Acute-on-chronic liver failure is an acute deterioration of liver function manifesting as
jaundice and coagulopathy with the development of ascites, with a high probability of …
jaundice and coagulopathy with the development of ascites, with a high probability of …
AASLD Practice guidance on Acute-on-chronic liver failure and the management of critically Ill patients with cirrhosis
The clinical stages of cirrhosis have traditionally been divided into a compensated phase
with no complications and a decompensated phase that manifests with complications of …
with no complications and a decompensated phase that manifests with complications of …
Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives
Vasoactive drugs form the mainstay of therapy for two of the most important complications of
liver disease: hepatorenal syndrome (HRS) and acute variceal bleed (AVB). With cumulative …
liver disease: hepatorenal syndrome (HRS) and acute variceal bleed (AVB). With cumulative …
Expert consensus on the use of human serum albumin in critically ill patients
YT Yu, J Liu, B Hu, RL Wang, XH Yang… - Chinese medical …, 2021 - mednexus.org
Human serum albumin (HSA) is a non-glycosylated, negatively charged, single-chain
polypeptide composed of 585 amino acid residues with a relative molecular mass of 66.438 …
polypeptide composed of 585 amino acid residues with a relative molecular mass of 66.438 …
Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography
Results: One hundred and forty patients were enrolled (84% men, 59% alcohol-associated
disease, mean MELD-Na 25±SD 5.6). A median daily dose of infused terlipressin was 4.3 …
disease, mean MELD-Na 25±SD 5.6). A median daily dose of infused terlipressin was 4.3 …
[HTML][HTML] Hepatorenal syndrome: Current concepts and future perspectives
CY Jung, JW Chang - Clinical and molecular hepatology, 2023 - ncbi.nlm.nih.gov
Hepatorenal syndrome (HRS), a progressive but potentially reversible deterioration of
kidney function, remains a major complication in patients with advanced cirrhosis, often …
kidney function, remains a major complication in patients with advanced cirrhosis, often …
[HTML][HTML] Acute kidney injury in patients with Cirrhosis: Acute Disease Quality Initiative (ADQI) and international Club of ascites (ICA) joint multidisciplinary consensus …
Patients with cirrhosis are prone to develop acute kidney injury (AKI), a complication
associated with a markedly increased in-hospital morbidity and mortality, along with a risk of …
associated with a markedly increased in-hospital morbidity and mortality, along with a risk of …